![Michael Bettess](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Bettess
Chairman at
Currus Biologics Pty Ltd.
Profile
Michael Bettess is currently the Chairman at Currus Biologics Pty Ltd., the Director at Cincera Therapeutics Pty Ltd., and the Senior Investment Manager at Brandon Capital Partners Pty Ltd. He previously worked as the Director at Heart Metabolics Ltd. and as the Investment Manager at Trans Tasman Fund Management Pty Ltd. Dr. Bettess obtained an MBA from LaTrobe University in 2008.
Michael Bettess active positions
| Companies | Position | Start |
|---|---|---|
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Private Equity Investor | 01/02/2016 |
Cincera Therapeutics Pty Ltd.
 Cincera Therapeutics Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Develops molecule drugs | Director/Board Member | - |
Currus Biologics Pty Ltd.
 Currus Biologics Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops cell therapies to treat cancers | Chairman | - |
Former positions of Michael Bettess
| Companies | Position | End |
|---|---|---|
Trans Tasman Fund Management Pty Ltd.
 Trans Tasman Fund Management Pty Ltd. Investment ManagersFinance TTCF invests in early stage commercialization of intellectual property developed at the University of Auckland and four Australian universities. It focuses on companies operating in the fields of technology, life sciences, information & communication technology and engineering/cleantech and also provides pre-seed, seed & early stage capital with an follow on investments. | Private Equity Investor | - |
Heart Metabolics Ltd.
 Heart Metabolics Ltd. BiotechnologyHealth Technology Develops medical therapy for the treatment of heart failure | Director/Board Member | - |
Training of Michael Bettess
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
27
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
LaTrobe University
 LaTrobe University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Trans Tasman Fund Management Pty Ltd.
Trans Tasman Fund Management Pty Ltd. Investment ManagersFinance TTCF invests in early stage commercialization of intellectual property developed at the University of Auckland and four Australian universities. It focuses on companies operating in the fields of technology, life sciences, information & communication technology and engineering/cleantech and also provides pre-seed, seed & early stage capital with an follow on investments. | Finance |
Heart Metabolics Ltd.
Heart Metabolics Ltd. BiotechnologyHealth Technology Develops medical therapy for the treatment of heart failure | Health Technology |
Cincera Therapeutics Pty Ltd.
Cincera Therapeutics Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Develops molecule drugs | Commercial Services |
Currus Biologics Pty Ltd.
Currus Biologics Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops cell therapies to treat cancers | Health Technology |
- Stock Market
- Insiders
- Michael Bettess
